Trial Profile
A pharmacokinetic study comparing the overnight switch effect from Immediate-Release Topiramate (TPM-IR) to Extended-Release Trokendi Xr™ (SPN-538) in adults with partial-onset or primary generalized seizures
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Topiramate (Primary) ; Topiramate (Primary)
- Indications Generalised epilepsy; Partial epilepsies
- Focus Pharmacokinetics
- 11 Dec 2015 New trial record